What is KeifeRx?
Headquartered in Mclean, VA, KeifeRx is a biotechnology firm dedicated to advancing treatments for neurodegenerative diseases. The company's focus on this critical area of medical research positions it within a high-impact segment of the life sciences industry. The recent enterprise-level funding suggests a strong belief in KeifeRx's scientific approach and market potential.
How much funding has KeifeRx raised?
KeifeRx has raised a total of $6M across 1 funding round:
Series A
$6M
Series A (2021): $6M, investors not publicly disclosed
What's next for KeifeRx?
The substantial enterprise-level funding and recent strategic investment indicate that KeifeRx is poised for significant expansion and development. This capital infusion will likely fuel further research and development initiatives, potentially accelerating clinical trials and the progression of its therapeutic candidates. The company's trajectory suggests a move towards scaling operations and solidifying its position in the fight against neurodegenerative conditions.
See full KeifeRx company page